[go: up one dir, main page]

NO914968D0 - Benzodiazepinoner - Google Patents

Benzodiazepinoner

Info

Publication number
NO914968D0
NO914968D0 NO914968A NO914968A NO914968D0 NO 914968 D0 NO914968 D0 NO 914968D0 NO 914968 A NO914968 A NO 914968A NO 914968 A NO914968 A NO 914968A NO 914968 D0 NO914968 D0 NO 914968D0
Authority
NO
Norway
Prior art keywords
benzodiazepinones
Prior art date
Application number
NO914968A
Other languages
English (en)
Other versions
NO914968L (no
Inventor
Ming-Chu Hsu
Donna Mary Huryn
Steve Yik-Kai Tam
Original Assignee
Hoffmann La Roche
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hoffmann La Roche filed Critical Hoffmann La Roche
Publication of NO914968D0 publication Critical patent/NO914968D0/no
Publication of NO914968L publication Critical patent/NO914968L/no

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D207/00Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D207/02Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D207/30Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members
    • C07D207/32Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
    • C07D207/33Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms with substituted hydrocarbon radicals, directly attached to ring carbon atoms
    • C07D207/335Radicals substituted by nitrogen atoms not forming part of a nitro radical
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12Antivirals
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D231/00Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings
    • C07D231/02Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings
    • C07D231/10Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D231/12Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D233/00Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
    • C07D233/54Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
    • C07D233/64Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with substituted hydrocarbon radicals attached to ring carbon atoms, e.g. histidine
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D249/00Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms
    • C07D249/02Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms not condensed with other rings
    • C07D249/041,2,3-Triazoles; Hydrogenated 1,2,3-triazoles
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D403/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
    • C07D403/02Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
    • C07D403/04Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings directly linked by a ring-member-to-ring-member bond

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Oncology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Virology (AREA)
  • Communicable Diseases (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Pyrrole Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
NO91914968A 1990-12-17 1991-12-16 Benzodiazepinoner NO914968L (no)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US62855190A 1990-12-17 1990-12-17

Publications (2)

Publication Number Publication Date
NO914968D0 true NO914968D0 (no) 1991-12-16
NO914968L NO914968L (no) 1992-06-18

Family

ID=24519378

Family Applications (1)

Application Number Title Priority Date Filing Date
NO91914968A NO914968L (no) 1990-12-17 1991-12-16 Benzodiazepinoner

Country Status (18)

Country Link
EP (1) EP0491218A1 (no)
JP (1) JPH04275287A (no)
KR (1) KR920012070A (no)
CN (1) CN1062528A (no)
AU (1) AU8974191A (no)
BR (1) BR9105406A (no)
CA (1) CA2057646A1 (no)
CS (1) CS381891A3 (no)
FI (1) FI915915A7 (no)
HU (1) HUT59920A (no)
IE (1) IE914369A1 (no)
IL (1) IL100364A0 (no)
IS (1) IS3792A7 (no)
MX (1) MX9102580A (no)
NO (1) NO914968L (no)
PT (1) PT99821A (no)
YU (1) YU194691A (no)
ZA (1) ZA919850B (no)

Families Citing this family (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
TW221687B (no) * 1992-01-24 1994-03-11 Hoffmann La Roche
AU3497293A (en) * 1992-02-26 1993-09-13 F. Hoffmann-La Roche Ag Benzodiazepinones and medicines containing them
US6071895A (en) * 1992-03-11 2000-06-06 Narhex Limited Polar-substituted hydrocarbons
ATE253050T1 (de) 1992-03-11 2003-11-15 Narhex Ltd Aminderivate von oxo- und hydroxy- substituierten kohlenwasserstoffen
BR9306058A (pt) * 1992-03-11 1997-11-18 Narhex Ltd Derivados de amina de hidrocarbonetos oxo- e hidroxi- substituidos
US5888992A (en) * 1992-03-11 1999-03-30 Narhex Limited Polar substituted hydrocarbons
SI9300288A (sl) * 1992-06-16 1993-12-31 Hoffmann La Roche Benzodiazepini
US5663169A (en) * 1992-08-07 1997-09-02 Merck & Co., Inc. Benzoxazinones as inhibitors of HIV reverse transcriptase
US5939430A (en) * 1993-02-22 1999-08-17 Merrell Pharmaceuticals Inc. Combinations of retroviral inhibitors
CA2173131A1 (en) * 1993-09-30 1995-04-06 Koichi Shudo Benzolactam derivatives
IT1297090B1 (it) * 1997-12-01 1999-08-03 Barbara Ensoli Tat di hiv-1 o suoi derivati, da soli od in combinazione, a scopo vaccinale, profilattico e terapeutico, contro l'aids i tumori e le
DE19920955C2 (de) * 1999-05-06 2002-11-28 Wacker Chemie Gmbh 2-(Benz-)Imidazol-,2-(Benz-)Oxazol- und 2-(Benz-)Thiazol-substituierte Silane und Verfahren zu deren Herstellung
KR101125899B1 (ko) * 2002-09-20 2012-04-12 애로우 쎄라퓨틱스 리미티드 벤조디아제핀 유도체 및 이를 함유하는 약학 조성물
JP4705911B2 (ja) * 2003-06-26 2011-06-22 メルク・シャープ・エンド・ドーム・コーポレイション ベンゾジアゼピンcgrp受容体拮抗物質
GB0406280D0 (en) * 2004-03-19 2004-04-21 Arrow Therapeutics Ltd Chemical compounds
GB0406279D0 (en) * 2004-03-19 2004-04-21 Arrow Therapeutics Ltd Therapeutic compounds
GB0406282D0 (en) * 2004-03-19 2004-04-21 Arrow Therapeutics Ltd Therapeutic compounds
CA2622592A1 (en) 2005-09-19 2007-03-29 Arrow Therapeutics Limited Benzodiazepine derivatives for treating hepatitis c infection
RU2451673C2 (ru) 2006-03-29 2012-05-27 Ф. Хоффманн-Ля Рош Аг ПРОИЗВОДНЫЕ ПИРИДИНА И ПИРИМИДИНА В КАЧЕСТВЕ АНТАГОНИСТОВ mGluR2
CU20090172A7 (es) 2009-10-09 2011-10-05 Ct De Investigación Y Desarrollo De Medicamentos Sistemas tricíclicos y tetracíclicos con actividad sobre el sistema nervioso central y vascular
KR20160115996A (ko) * 2014-02-14 2016-10-06 인셉션 2 인코퍼레이티드 피라졸론 화합물 및 이의 용도

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NL279830A (no) * 1961-06-20
HUT61195A (en) * 1989-10-30 1992-12-28 Hoffmann La Roche Process for utilizing a benzodiazepine derivative and a phenylpyrrylketone derivative

Also Published As

Publication number Publication date
HU913960D0 (en) 1992-02-28
IS3792A7 (is) 1992-06-18
FI915915A0 (fi) 1991-12-16
HUT59920A (en) 1992-07-28
PT99821A (pt) 1992-12-31
EP0491218A1 (en) 1992-06-24
CN1062528A (zh) 1992-07-08
ZA919850B (en) 1992-08-26
MX9102580A (es) 1992-06-01
JPH04275287A (ja) 1992-09-30
CA2057646A1 (en) 1992-06-18
BR9105406A (pt) 1992-08-25
IL100364A0 (en) 1992-09-06
FI915915L (fi) 1992-06-18
NO914968L (no) 1992-06-18
KR920012070A (ko) 1992-07-25
YU194691A (sh) 1994-01-20
CS381891A3 (en) 1992-07-15
IE914369A1 (en) 1992-06-17
AU8974191A (en) 1992-06-18
FI915915A7 (fi) 1992-06-18

Similar Documents

Publication Publication Date Title
DK0439279T3 (da) Borerørs-/foringsbeskyttelsesorgan
FI932069A0 (fi) Injektionsspruta
FI931708A7 (fi) Herbicida substituerade aryl-haloalkylpyrazoler
ATA150090A (de) Hoergeraet
FI931359A0 (fi) Tvaettmedelskompositioner innehaollande polyhydroxifettsyraamid- och alkylestersulfonattensider
FI931667A7 (fi) Indolderivat
FI932325L (fi) Gelbildande vaetskemediumsammansaettning
FI932150A7 (fi) Analyssystem foer glykerande blodproteiner
FI924971A0 (fi) Pressvals
FI931369A0 (fi) Flytande detergentkompositioner
FI930058L (fi) O-glykolyserad alfa-ifn
FI104051B1 (fi) Sisäänhengityslaite
FI925594A0 (fi) Fotografiserie
FI925715A7 (fi) Endonukleaser
FI932680A0 (fi) Fusionspolypeptider
FI930535A0 (fi) Foerpackningssystem
NO914968L (no) Benzodiazepinoner
FI932324L (fi) Gelbildande flytande naeringsfibersammansaettning
FI931381A0 (fi) Akustisk saendare
DE69132958D1 (de) Flüssigkristallpolyacrylate
FI931784A7 (fi) Motsols roterande repningskniv foer framfoeringsspets
DE59107143D1 (de) N-Heteroaryl-2-nitroaniline
DK174891A (da) Benzodiazepinderivater
FI924294A7 (fi) y-CGTaasi
FI925426A0 (fi) Flytande antiperspirantkompositioner